CEIVD-Fast-PCR-2.0-saliva-banner.

An ideal choice for high-frequency testing—enabling fast, trusted COVID-19 test results from raw saliva

Thermo Fisher Scientific continues to provide the gold standard of testing with our evolved Emergency Use Authorized (EUA) PCR-based TaqPath COVID-19 2.0 tests, which were developed to help laboratories quickly diagnose COVID-19 caused by SARS-CoV-2 infection.

The TaqPath COVID-19 Fast PCR Combo Kit 2.0 was designed with an innovative, multi-target assay design to compensate for current and future emerging SARS-CoV-2 mutations. Our advanced PCR-based test enables fast, trusted COVID-19 test results from raw saliva, making it an ideal choice for high-frequency testing.

Features of the TaqPath COVID-19 Fast PCR 2.0 Combo Kit 2.0 include:

  • Compatible with raw saliva (no preservatives) for symptomatic and asymptomatic individuals
  • Utilizes human sample confirmation RNase P gene as an internal control
  • Go from sample to results in ~2 hours (bypassing RNA extraction)
taqpath-ceivd-fast-pcr-2.0-poster

Fill out the form and read the poster and application note to learn more.
*
*
*
*
*
*
 
 Yes
 No

I would like Thermo Fisher Scientific (including its affiliates) to add me to a list to receive information events, products, services and promotions which Thermo Fisher believes may be of interest to me via the following channels:

 Email
 Phone

I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com
I acknowledge Thermo Fisher Scientific (including its affiliates) will process my Personal Information according to its Privacy Policy, which includes information about my rights.

Ce site est protégé par reCAPTCHA. Les règles de confidentialité et les conditions d’utilisation de Google s’appliquent.

 
 

 

For Emergency Use Authorization. For in vitro diagnostics. For Prescription use only.